ANAPLASTIC MIXED OLIGOASTROCYTOMA
Clinical trials for ANAPLASTIC MIXED OLIGOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC MIXED OLIGOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC MIXED OLIGOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat brain cancers
Disease control OngoingThis early-stage study tested the safety and best dose of vorinostat when given with the chemotherapy drug temozolomide in 83 adults with aggressive brain tumors called malignant gliomas. The goal was to see if adding vorinostat could make the tumor cells more sensitive to chemot…
Matched conditions: ANAPLASTIC MIXED OLIGOASTROCYTOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Chemo delivered straight to the brain: new hope for deadly tumors?
Disease control TerminatedThis study tests a technique that delivers two cancer drugs, bevacizumab and carboplatin, directly into the brain's arteries for people with recurrent glioblastoma or anaplastic astrocytoma. The goal is to see if this method is safe and can slow tumor growth better than standard …
Matched conditions: ANAPLASTIC MIXED OLIGOASTROCYTOMA
Phase: PHASE1, PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC